Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


Clinical updates from the EHA 2017 part 2

The 22nd European Hematology Association (EHA) took place in Madrid, Spain, on 22-25 June 2017.

An international multidisciplinary panel discussed a selection of topics and new data on hematology during a live program. They gave an answer to what this newly acquired knowledge means for clinical practice.

Topics

  • Immunotherapy for childhood ALL
  • CML treatment in children and adults
  • Treatment reduction in Hodgkin Lymphoma
  • Fertility preservation
  • The role of the microbiome to improve survival after allogeneic stem cell transplantation
  • Prof. Harry Schouten, MD – hematologist, Maastricht UMC+, Maastricht, The Netherlands

Speakers

  • Thamer Sliwa, MD – hematologist, Hanusch Krankenhaus, Vienna, Austria
  • Prof. Michel Zwaan, MD – pediatric hematologist, EMC, Rotterdam, The Netherlands

Moderator

  • Prof. Harry Schouten, MD – hematologist, Maastricht UMC+, Maastricht, The Netherlands
  • Sponsors

    This program is editorially independent and is financially made possible by

Related items

Meet the author 11/10/2018

Quarterly Hematology: highlights in Hodgkin Lymphoma

Publications in peer-reviewed journals are a major source for keeping up with the latest developments in your field. However, you may not always have sufficient time to study (difficult) publications thoroughly and to determine the impact on your clinical practice. To support you, MEDtalks Hematology has developed a program format: the Quarterly Focus. This innovative program brings an expert panel and authors of relevant, selected publications together to explain and discuss the new data. Two high-impact international publications on Hodgkin Lymphoma of the past year will be clarified by one of the authors and will be thoroughly discussed by an expert panel including the author. The program will give you the possibility to gain more insight into the selected publications. During this live broadcast you will have the unique opportunity to interact with our expert panel and the authors and ask them your questions. The expert panel consists of: Josée Zijlstra, MD, PhD, hematologist, VUmc Amsterdam Wouter Plattel, MD, PhD, hematologist, UMC Groningen Live video guests: HD18: Prof. Peter Borchmann, MD, PhD, hematologist, University Hospital of Cologne, Germany H10: Prof. Massimo Federico, MD, hematologist, University of Modena and Reggio Emilia, Italy

Congresnieuws 25/06/2017

Clinical updates from the EHA 2017 part 1

The 22nd European Hematology Association (EHA) took place in Madrid, Spain, on 22-25 June 2017. An international multidisciplinary panel discussed a selection of topics and new data on hematology during a live program. They gave an answer to what this newly acquired knowledge means for clinical practice. Topics New immunotherapy data for lymphoma The mechanisms behind iron overload New diagnostic markers for ITP Speakers Alicia Rovó, MD – hematologist, University Hospital of Bern, Bern, Switzerland Sigrid Machherndl-Spandl, MD – hematologist, Elisabethinen Hospital, Linz, Austria Moderator Prof. Harry Schouten, MD – hematologist, Maastricht UMC+, Maastricht, The Netherlands

Congresnieuws 08/12/2014

ASH 2014 Highlight 3 - Leukemia

Highlight on leukemia: Prof. Dr. med. Uwe Platzbecker tells if ATRA+arsenicumtrioxide should become the new standard care for non-high risk APML by illustrating the Italian-German APL0406 trial. Ian Flinn MD PhD provides an overview on novel therapies for CLL. Prof. Dr. Michele Baccarani discusses whether imatinib remains the standard therapy for CML by elaborating on the DASISION, SPIRIT-2 and EPIC trails. Prof. Dr. Rien van Oers concludes with the PROLONG trial which investigates ofatumumab maintenance therapy in R/R CLL.

Congresnieuws 22/07/2014

Extra Edition EHA 2014 News Report: Multiple Myeloma

Extra Edition EHA News Report: Multiple Myeloma In an interview on the highlights on multiple myeloma presented at EHA, Prof. Pieter Sonneveld discusses three trials investigating different therapy combinations in newly diagnosed patients, HDAC inhibitors (PANORAMA-1 trial) and antibodies against CD-38 in relapsed/refractory multiple myeloma and the use of flow cytometry and PET/CT for monitoring response in MM.

Congresnieuws 14/06/2014

EHA 2014 - News Report 2

In the second EHA News Report Dr. Ali Taher discusses the latest news on Red blood cells and iron, Prof. Hervé Dombret highlights several interesting presentations on ALL and Prof. Alessandro Vannucchi focusses on various presentations around MPN. Our last guest, Prof. Michael Pfreundschuh discusses the latest news on Non-Hodgkin Lymphoma.

Congresnieuws 14/06/2014

EHA 2014 News Report 3

In the third EHA News Report, Prof. Anna Falanga highlights the three presentations held at the Education Session on Thrombosis, Prof. Richard Schlenk reviews a selection of presentations regarding AML and Prof. Andreas Hochhaus discusses the highlights of the EHA congress on CML.

Congresnieuws 12/06/2014

EHA 2014 - News Report 1

EHA 2014 – News Report 1 on: CLL by Prof. Stephan Stilgenbauer, the José Carreras Lecture ‘Genetics to guide management of patients with AML by Prof. Hartmut Döhner, the pathophysiology of auto-immune hemolytic anemia by Prof. Hannah Tamary and Stem Cell Transplantation: focus on chronic GvHD by Prof William Arcese.